Ghost Tree Capital »

Biohaven shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Biohaven shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $17M 349k 49.97

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Biohaven Call
Sarepta Therapeutics (SRPT)
Novo-nordisk A S Adr (NVO)
Blueprint Medicines (BPMC)
Axsome Therapeutics (AXSM)
Tarsus Pharmaceuticals (TARS)
Perspective Therapeutics Com New (CATX)
Cg Oncology (CGON)
Roivant Sciences SHS (ROIV)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Viking Therapeutics (VKTX)
Syndax Pharmaceuticals (SNDX)
Janux Therapeutics (JANX)

View all positions for Ghost Tree Capital

Top funds holding Biohaven

Ikarian Capital
Oracle Investment Management
Simplex Trading
Group One Trading
IMC-Chicago

View all funds holding Biohaven